Effects of Serum Cytochrome c on Contrast-Induced Nephropathy in Patients with ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention

الملخص EN

Background and Aims.

Contrast-induced nephropathy (CIN) is a relatively infrequent complication after percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction (STEMI).

However, little is known about the association between cytochrome c (cyt c) and increased risk of CIN.

We conducted this study to explore the impact of serum cyt c on the occurrence of CIN.

Methods.

We prospectively examined cyt c levels before undergoing PCI in 240 patients with STEMI.

The logistic regression was performed to identify the independent risk factors for the occurrence of CIN.

The receiver operating characteristic (ROC) analysis was employed to evaluate the predictive value of cyt c for the occurrence of CIN.

Results.

29 patients (12.1%) had developed CIN after the PCI procedure.

The cyt c levels at baseline were significantly higher in patients who developed CIN than those in non-CIN group (0.65±0.08 versus 0.58±0.1; P = 0.001).

The multivariate logistic regression showed that cyt c was an independent risk factor for the occurrence of CIN (OR, 7.421; 95% CI, 6.471–20.741; P = 0.034) after adjusting for age, history of hypertension and diabetes mellitus, levels of creatinine, uric acid, and glucose.

The ROC curve analysis showed that the area under the curve of cyt c was 0.697 (95% CI, 0.611–0.783; P = 0.001), and cyt c > 0.605 ng/mL predicted CIN with sensitivity of 79.3% and specificity of 56.9%.

Conclusion.

Our results show that a higher cyt c level was significantly associated with the occurrence of CIN after PCI in STEMI patients.

This study has been registered in the Chinese Clinical Trial Registry.

The clinical trial registration number is ChiCTR1800019368.